Published in
Elsevier, Seminars in Arthritis and Rheumatism, 6(48), p. 967-975, 2019
DOI: 10.1016/j.semarthrit.2018.10.006
Links
Tools
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
Journal article published in 2019 by
Jocelyn Quistrebert 
,
Signe Hässler ,
Delphine Bachelet,
Cyprien Mbogning,
Anne Musters,
Paul Peter Tak,
Carla Ann Wijbrandts,
Marieke Herenius,
Sytske Anne Bergstra,
Gülşah Akdemir ,
Martina Johannesson,
Bernard Combe,
Bruno Fautrel,
Sylvie Chollet-Martin ,
Aude Gleizes
and other authors.
,
Signe Hässler ,
Delphine Bachelet,
Cyprien Mbogning,
Anne Musters,
Paul Peter Tak,
Carla Ann Wijbrandts,
Marieke Herenius,
Sytske Anne Bergstra,
Gülşah Akdemir ,
Martina Johannesson,
Bernard Combe,
Bruno Fautrel,
Sylvie Chollet-Martin ,
Aude Gleizes
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 